A citation-based method for searching scientific literature

Michael A Kass, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson, Mae O Gordon. Arch Ophthalmol 2002
Times Cited: 2400







List of co-cited articles
430 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Anders Heijl, M Cristina Leske, Bo Bengtsson, Leslie Hyman, Boel Bengtsson, Mohamed Hussein. Arch Ophthalmol 2002
43

Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.
Yih-Chung Tham, Xiang Li, Tien Y Wong, Harry A Quigley, Tin Aung, Ching-Yu Cheng. Ophthalmology 2014
36


Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
M Cristina Leske, Anders Heijl, Mohamed Hussein, Bo Bengtsson, Leslie Hyman, Eugene Komaroff. Arch Ophthalmol 2003
22

The number of people with glaucoma worldwide in 2010 and 2020.
H A Quigley, A T Broman. Br J Ophthalmol 2006
22

The pathophysiology and treatment of glaucoma: a review.
Robert N Weinreb, Tin Aung, Felipe A Medeiros. JAMA 2014
20


The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.
Mae O Gordon, Julia A Beiser, James D Brandt, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson,[...]. Arch Ophthalmol 2002
14

Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.
P R Lichter, D C Musch, B W Gillespie, K E Guire, N K Janz, P A Wren, R P Mills. Ophthalmology 2001
752
13


Predictors of long-term progression in the early manifest glaucoma trial.
M Cristina Leske, Anders Heijl, Leslie Hyman, Boel Bengtsson, LiMing Dong, Zhongming Yang. Ophthalmology 2007
890
10

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.
David F Garway-Heath, David P Crabb, Catey Bunce, Gerassimos Lascaratos, Francesca Amalfitano, Nitin Anand, Augusto Azuara-Blanco, Rupert R Bourne, David C Broadway, Ian A Cunliffe,[...]. Lancet 2015
312
10

Primary Open-Angle Glaucoma Preferred Practice Pattern(Ā®) Guidelines.
Bruce E Prum, Lisa F Rosenberg, Steven J Gedde, Steven L Mansberger, Joshua D Stein, Sayoko E Moroi, Leon W Herndon, Michele C Lim, Ruth D Williams. Ophthalmology 2016
304
8

Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.
Steven J Gedde, Leon W Herndon, James D Brandt, Donald L Budenz, William J Feuer, Joyce C Schiffman. Am J Ophthalmol 2012
441
8

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho KinaseĀ Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Janet B Serle, L Jay Katz, Eugene McLaurin, Theresa Heah, Nancy Ramirez-Davis, Dale W Usner, Gary D Novack, Casey C Kopczynski. Am J Ophthalmol 2018
99
8

Primary open-angle glaucoma.
Robert N Weinreb, Peng Tee Khaw. Lancet 2004
7

Glaucoma.
Jost B Jonas, Tin Aung, Rupert R Bourne, Alain M Bron, Robert Ritch, Songhomitra Panda-Jonas. Lancet 2017
431
7

The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Paula Anne Newman-Casey, Alan L Robin, Taylor Blachley, Karen Farris, Michele Heisler, Ken Resnicow, Paul P Lee. Ophthalmology 2015
173
7

Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
David C Musch, Brenda W Gillespie, Paul R Lichter, Leslie M Niziol, Nancy K Janz. Ophthalmology 2009
258
7

Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
Kouros Nouri-Mahdavi, Douglas Hoffman, Anne L Coleman, Gang Liu, Gang Li, Douglas Gaasterland, Joseph Caprioli. Ophthalmology 2004
472
7

Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract.
Thomas W Samuelson, L Jay Katz, Jeffrey M Wells, Yi-Jing Duh, Jane Ellen Giamporcaro. Ophthalmology 2011
312
6

Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey.
A Sommer, J M Tielsch, J Katz, H A Quigley, J D Gottsch, J Javitt, K Singh. Arch Ophthalmol 1991
817
6

Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma.
S Asrani, R Zeimer, J Wilensky, D Gieser, S Vitale, K Lindenmuth. J Glaucoma 2000
587
6

Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis.
Carlo Lavia, Laura Dallorto, Milena Maule, Manuela Ceccarelli, Antonio Maria Fea. PLoS One 2017
167
6

Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gus Gazzard, Evgenia Konstantakopoulou, David Garway-Heath, Anurag Garg, Victoria Vickerstaff, Rachael Hunter, Gareth Ambler, Catey Bunce, Richard Wormald, Neil Nathwani,[...]. Lancet 2019
167
6

Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure.
Jason Bacharach, Harvey B Dubiner, Brian Levy, Casey C Kopczynski, Gary D Novack. Ophthalmology 2015
79
7


The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
Paula Anne Newman-Casey, Leslie M Niziol, Brenda W Gillespie, Nancy K Janz, Paul R Lichter, David C Musch. Ophthalmology 2020
40
15

Risk factors for open-angle glaucoma. The Barbados Eye Study.
M C Leske, A M Connell, S Y Wu, L G Hyman, A P Schachat. Arch Ophthalmol 1995
496
5

Risk factors for incident open-angle glaucoma: the Barbados Eye Studies.
M Cristina Leske, Suh-Yuh Wu, Anselm Hennis, Robert Honkanen, Barbara Nemesure. Ophthalmology 2008
481
5

Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Alan L Robin, Gary D Novack, David W Covert, R Stephens Crockett, Tania S Marcic. Am J Ophthalmol 2007
236
5

Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Makoto Araie. Am J Ophthalmol 2013
121
5

Number of people with glaucoma worldwide.
H A Quigley. Br J Ophthalmol 1996
5



Prevalence of glaucoma. The Beaver Dam Eye Study.
B E Klein, R Klein, W E Sponsel, T Franke, L B Cantor, J Martone, M J Menage. Ophthalmology 1992
731
5

Micro-invasive glaucoma surgery: current perspectives and future directions.
Hady Saheb, Iqbal Ike K Ahmed. Curr Opin Ophthalmol 2012
297
5

Global data on visual impairment in the year 2002.
Serge Resnikoff, Donatella Pascolini, Daniel Etya'ale, Ivo Kocur, Ramachandra Pararajasegaram, Gopal P Pokharel, Silvio P Mariotti. Bull World Health Organ 2004
5

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
5

Persistence and adherence with topical glaucoma therapy.
Beth L Nordstrom, David S Friedman, Essy Mozaffari, Harry A Quigley, Alexander M Walker. Am J Ophthalmol 2005
287
5

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2).
Malik Y Kahook, Janet B Serle, Francis S Mah, Terry Kim, Michael B Raizman, Theresa Heah, Nancy Ramirez-Davis, Casey C Kopczynski, Dale W Usner, Gary D Novack. Am J Ophthalmol 2019
39
12

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension.
Richard A Lewis, Brian Levy, Nancy Ramirez, Casey C Kopczynski, Dale W Usner, Gary D Novack. Br J Ophthalmol 2016
57
8

High myopia and glaucoma susceptibility the Beijing Eye Study.
Liang Xu, Yaxing Wang, Shuang Wang, Yun Wang, Jost B Jonas. Ophthalmology 2007
375
5

The Effect of Phacoemulsification on Intraocular Pressure in Glaucoma Patients: A Report by the American Academy of Ophthalmology.
Philip P Chen, Shan C Lin, Anna K Junk, Sunita Radhakrishnan, Kuldev Singh, Teresa C Chen. Ophthalmology 2015
121
5

Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up.
Steven J Gedde, Joyce C Schiffman, William J Feuer, Leon W Herndon, James D Brandt, Donald L Budenz. Am J Ophthalmol 2012
577
5



Glaucoma treatment trends: a review.
Ronan Conlon, Hady Saheb, Iqbal Ike K Ahmed. Can J Ophthalmol 2017
121
5

Early Manifest Glaucoma Trial: design and baseline data.
M C Leske, A Heijl, L Hyman, B Bengtsson. Ophthalmology 1999
349
5

Ripasudil: first global approval.
Karly P Garnock-Jones. Drugs 2014
131
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.